Detalhe da pesquisa
1.
Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma.
Blood;
130(8): 974-981, 2017 08 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28637662
2.
Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes.
Biol Blood Marrow Transplant;
22(7): 1197-1205, 2016 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27040394
3.
A phase 1 dose-escalation study of filanesib plus bortezomib and dexamethasone in patients with recurrent/refractory multiple myeloma.
Cancer;
122(21): 3327-3335, 2016 Nov 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27433944
4.
Filanesib plus bortezomib and dexamethasone in relapsed/refractory t(11;14) and 1q21 gain multiple myeloma.
Cancer Med;
11(2): 358-370, 2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34921527
5.
Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.
Blood;
113(21): 5074-82, 2009 May 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19270260
6.
Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma.
Proc Natl Acad Sci U S A;
104(52): 20884-9, 2007 Dec 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18093940
7.
Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes.
Biol Blood Marrow Transplant;
15(5): 554-63, 2009 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19361747
8.
Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma.
Leuk Res;
74: 130-136, 2018 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30055822
9.
Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial.
J Clin Oncol;
31(33): 4199-206, 2013 Nov 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24127452
10.
Taming cancer by inducing immunity via dendritic cells.
Immunol Rev;
220: 129-50, 2007 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17979844
11.
Both Langerhans cells and interstitial DC cross-present melanoma antigens and efficiently activate antigen-specific CTL.
Eur J Immunol;
37(9): 2657-67, 2007 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17683111
12.
Dendritic cell subsets in health and disease.
Immunol Rev;
219: 118-42, 2007 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17850486
13.
Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34(+) progenitor-derived dendritic cells.
Cancer Immunol Immunother;
55(10): 1209-18, 2006 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16331519
14.
Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations.
Blood;
105(4): 1408-16, 2005 Feb 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15486071
15.
Hematopoietic growth factors, dendritic cell biology, and vaccine therapy of cancer.
Curr Opin Hematol;
9(3): 202-6, 2002 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-11953665
16.
Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.
Blood;
101(5): 2015-23, 2003 Mar 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12393427
17.
History of the Baylor Charles A. Sammons Cancer Center.
Proc (Bayl Univ Med Cent);
16(1): 30-58, 2003 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16278720